Introduction
============

Epigenetic modification of genomic DNA and associated histone proteins are crucial regulatory signals allowing eukaryotic cells the ability to adapt to dynamic environmental conditions \[[@r1]\]. DNA methylation is the covalent addition of a methyl group to the C-5 position of cytosine bases in genomic DNA. This addition is catalyzed by structurally distinct DNA methyltransferase (Dnmt) enzyme family members \[[@r2],[@r3]\]. In plant and vertebrate genomes, DNA methylation is required for normal development and function of organisms \[[@r4],[@r5]\]. DNA methylation has been linked to many key processes in vertebrate genomes, such as X-chromosome inactivation \[[@r6]\], regulation of tissue-specific gene expression \[[@r7]\], and suppression of mobile element transposition \[[@r8]\]. Dysregulation of DNA methylation-related epigenetic mechanisms is associated with human disease \[[@r9],[@r10]\]. Although DNA methylation has an increasingly appreciated role in complex genome regulation, the specific biochemical underpinnings of how this modification modulates the genome remain unclear.

Recent evidence demonstrates that DNA methylation regulates transcription within the retina. Cone and rod photoreceptor-specific genes display cell-specific patterns of DNA methylation, which appear to play an important role in the establishment and maintenance of retinal cell type--restricted gene expression \[[@r11],[@r12]\]. Furthermore, targeted retina-specific disruption of Dnmts in murine models result in abnormal development of retinal neurons and dysregulation of global retinal gene expression \[[@r13]-[@r15]\]. Collectively, these findings hint at an important role for epigenetic modification of DNA during retinal differentiation and maturation. However, deciphering the mechanistic detail of this role is vital for gaining insight into retinal function and retinal regeneration and developing novel therapeutic strategies for retinal degeneration.

The homeodomain transcription factor cone-rod homeobox (CRX) protein is required for proper maturation of rod and cone photoreceptors \[[@r16],[@r17]\]. Mutations in CRX result in the blinding retinal degenerative diseases cone-rod dystrophy, Leber congenital amaurosis, and retinitis pigmentosa \[[@r18]\]. CRX mediates complex photoreceptor-specific transcriptional networks through physical interaction with evolutionarily conserved DNA sequence motifs \[[@r19],[@r20]\]. Despite the presence of hundreds of thousands of these cis-regulatory elements in the mouse genome, fewer than 6,000 functional CRX binding regions (CBRs) have been identified in the murine retina. Furthermore, a subset of these CBRs display cell-type specific affinity in mouse rods and cones \[[@r19]\]. Beyond the nucleotide sequence context, genomic features responsible for regulating the spatial and temporal binding of CRX are poorly understood and represent a considerable gap in our knowledge of photoreceptor development. One potential model for this differential binding is the dynamic epigenetic modification of the genome influencing local chromatin conformation and accessibility to transcriptional regulators, such as CRX. Evidence in model systems demonstrates that several CRX-dependent genes have an inverse correlation between DNA methylation and gene expression \[[@r11],[@r12]\]. Here, we expand on these findings by demonstrating a similar relationship for the first time in primary human retinal tissue. We also use molecular modeling to build evidence that reversible DNA methylation proximal to CRX binding motifs alters structural characteristics of the DNA double helix, including minor and major groove width and DNA flexibility that may modulate CRX binding. Collectively, this study offers compelling evidence that DNA methylation plays a critical role in epigenetic regulation of human photoreceptor neurons and provides insight into the biochemical interactions underlying this mode of regulation.

Methods
=======

Tissue collection
-----------------

Deidentified post-mortem human donor eyes procured from three individuals with no reported ocular disease (National Disease Research Interchange, Philadelphia, PA) were used to collect ocular tissues for gene-specific quantification of DNA methylation. All donor tissue was collected within 8 h of donor death (Appendix 1). The tissue was shipped from the donor location submerged in saline on wet ice and received within 24 h of donor death (Appendix 1). A scalpel was used to pierce the limbus followed by collection of the cornea using scissors. Whole corneas were flash frozen, ground into a fine powder using a mortar and pestle, and then immediately transferred to nucleic acid extraction buffer and stored at −80 °C. Eyecups were further dissected with scissors by making four radial cuts exposing the retina. Cuts posterior to the ciliary margin were made liberating the retina from the anterior portion of the eye. The vitreous was removed, and the retina was carefully peeled away from the eyecup using fine forceps. Whole retina from each donor was briefly washed in Hank's Balanced Salt Solution without calcium or magnesium to rinse away contaminating RPE cells, placed in nucleic acid extraction buffer, vigorously vortexed, and stored at −80 °C.

Nucleic acid purification
-------------------------

Genomic DNA was extracted from human ocular tissues using a Qiagen AllPrep Kit (Hilden, Germany) per the manufacturer's instructions. Briefly, lysates were homogenized using QIAshredder spin columns. Lysate flow-through was then transferred to silica-based spin columns where genomic DNA and RNA were sequentially purified. The quality and quantity of the DNAs were examined using ultraviolet (UV) spectrophotometry.

Bisulfite pyrosequencing
------------------------

Quantitative analysis of DNA methylation was measured using bisulfite pyrosequencing performed as previously described \[[@r14],[@r21]\]. Briefly, bisulfite conversion was performed on 200 ng genomic DNA using the EZ DNA Methylation-Gold Kit (Zymo, Irvine, CA). Following conversion, 30 μl PCR reactions were performed using 2X JumpStart Taq ReadyMix (Sigma-Aldrich, St. Louis, MO). 5′ biotinylated PCR primers were designed to the 5′ regulatory regions of the target genes using PyroMark Assay Design 2.0 software (Qiagen, Hilden, Germany). Commercially available 5′ biotinylated PCR primers were used to amplify the 5′ promoters of LINE1 retrotransposon repeats (Qiagen). The PCR cycling conditions were 95 °C for 1 min, followed by 45 cycles of 95 °C for 30 s, 50--58 °C for 30 s, and 72 °C for 30 s, with a final extension at 72 °C for 1 min on a Bio-Rad C1000 Touch Thermal Cycler (Bio-Rad, Hercules, CA). Variable PCR annealing temperatures for different primer sets are indicated in [Table 1](#t1){ref-type="table"}. Biotinylated PCR products were purified and made single stranded to serve as a template in a pyrosequencing reaction using the PyroMark Q24 Vacuum Prep Tool (Qiagen) per the manufacturer's instructions. A sequencing primer (0.3 μM final) was annealed to the purified single-stranded PCR product, and pyrosequencing reactions were performed using the PyroMark Q24 Pyrosequencing System (Qiagen) per the manufacturer's instructions. Percent DNA methylation at each CpG dinucleotide in the bisulfite PCR amplicon was determined and averaged between biologic triplicates. Statistical significance between the two sample groups was determined using a one-tailed *t* test with the significance threshold set at 0.01. All PCR and sequencing primers used in these experiments are shown in [Table 1](#t1){ref-type="table"}.

###### Oligonucleotides used for bisulfite PCR and pyrosequencing analysis.

  [Primer Name]{.ul}   [Sequence (5′-3′)]{.ul}                  [Region Analyzed]{.ul}   [Amplicon Size (bp)]{.ul}   [Annealing temp (°C)]{.ul}   [Application]{.ul}
  -------------------- ---------------------------------------- ------------------------ --------------------------- ---------------------------- --------------------
  hLINE1F              proprietary (Qiagen product \# 970042)   LINE1 promoters          146                         50                           BS PCR
  hLINE1R              proprietary (Qiagen product \# 970042)   LINE1 promoters          146                         50                           BS PCR
  hLINE1-seq           proprietary (Qiagen product \# 970042)   LINE1 promoters          N/A                         N/A                          pyrosequencing
  hPax6-F1             TAGTTATAGGTYGGGTTAAGGAAGGTTAAA           PAX6 promoter            248                         58                           BS PCR
  hPax6-R1             Bio-AACCTACCCCAAAATTTAAATATCAA           PAX6 promoter            248                         58                           BS PCR
  hPax6-seq1           ATTAGTYGGYGTAGAGTTGTGTTTA                PAX6 promoter            N/A                         N/A                          pyrosequencing
  hPde6b-F1            TGGGAAGTTTTAGGGTTTGAGG                   PDE6B promoter           120                         58                           BS PCR
  hPde6b-R1            Bio-AAAACCCTATCATCAACAAAATCTTTCTTA       PDE6B promoter           120                         58                           BS PCR
  hPde6b-seq1          TTTAGGGTTTGAGGAGA                        PDE6B promoter           N/A                         N/A                          pyrosequencing
  hRho-F3              TTGAGTTGGGATTTTGGGATAGATAAG              RHO promoter             241                         58                           BS PCR
  JhRho-R3             Bio-TATAAAATAACCTCCCCCTCCT               RHO promoter             241                         58                           BS PCR
  hRho-S3              TTTGGTTTTTTTTAGAAGTTAATTA                RHO promoter             N/A                         N/A                          pyrosequencing
  hRho-F4              AGGGGTTTGTAAATAAATGTTTAATGA              RHO promoter             258                         56                           BS PCR
  hRho-R4              Bio-ACTTTCTAATTTATTCTCCCAATCTCT          RHO promoter             258                         56                           BS PCR
  hRho-seq4-2          ATTGGATGATTTTAGAGGT                      RHO promoter             N/A                         N/A                          pyrosequencing
  hRER-F2              Bio-GTGGGTTAGTTTTGATTTAAGGTAT            RHO Enhancer             284                         58                           BS PCR
  hRER-R2              CCCAAAATTCCCAAATCTATCTACTCAA             RHO Enhancer             284                         58                           BS PCR
  hRER-seq2-1          ACAAAACCAATAAAATAAAACCTCT                RHO Enhancer             N/A                         N/A                          pyrosequencing

Bio indicates a biotinylation modification on the 5′ end of oligos.

Bioinformatics analysis of CRX binding sites
--------------------------------------------

Computationally predicted CBRs in the human genome were generated from CBRs obtained from a previously published CRX chromatin immunoprecipitation study of mouse photoreceptors \[[@r19]\]. Genome coordinates from experimentally validated CBRs in the mouse mm9 genome assembly were downloaded, aligned, and mapped to the human hg19 genome assembly using the LiftOver tool available within the [UCSC Genome Browser](https://genome.ucsc.edu) \[[@r22]\]. These data were then built as a custom track in the UCSC Genome Browser's hg19 genome assembly viewer and were overlaid with adult human retina RNA-sequencing transcriptome data as determined by Farkas and colleagues \[[@r23]\], vertebrate conservation data \[[@r24]\], and custom tracks created in the UCSC Genome Browser highlighting predicted and experimentally validated CRX binding sites \[[@r25]\].

Homology modeling of human CRX binding site
-------------------------------------------

The UniProt accession number O43186 was used for modeling and assembly of human CRX \[[@r26]\]. The DNA binding domain of CRX, consisting of amino acids 39--98, was generated using SWISS-MODEL \[[@r27]\]. Models of the CRX DNA binding domains were energy minimized in Yet Another Scientific Artificial Reality Application (YASARA) before the docking experiments \[[@r28],[@r29]\].

Molecular modeling of the rhodopsin enhancer region and *RHO* promoter region
-----------------------------------------------------------------------------

The human rhodopsin enhancer region (RER) and *RHO* (OMIM [180380](https://www.omim.org/entry/180380); Gene ID: 6010) promoter sequences were obtained from UCSC Genome Browser and three-dimensional (3D) B-DNA structures generated using 3D-DART \[[@r30]\]. The 39-bp DNA construct for the RER consisted of the following bases: 5′-ACC TCA TTA GCG TTG GGC ATA ATC ACC AGG CCA AGC GCC-3′. The *RHO* promoter region consisted of the following 37 bps: 5′-TCT GCA GCG GGG ATT AAT ATG ATT ATG AAC ACC CC-3′. The DNA sequences were numbered in the 5′ to 3′ direction, continuing with the complementary strands. CpG methylation regions previously identified in this study were generated through YASARA. Methyl groups were built onto the C-5 position of the cytosine ring by using the "Swap\>Atom" function. Molecular dynamics modeling was conducted using the AMBER14 force field in YASARA. The cutoff for electrostatic interactions was set at 10.5 Å. The cell boundaries were periodic and filled with 0.3% magnesium chloride and water molecules at pH 7.0. The simulation was run at 298.1 K. The save interval was every 0.1 ns over the 100 ns of the simulation. All other parameters remained in the default setting.

Root mean square deviation (RMSD), Root mean square fluctuation (RMSF), and groove widths were calculated in YASARA. Groove widths were calculated by measuring the distance between the phosphate of one nucleotide to the phosphate of a nucleotide on opposite face of the groove. For the CRX binding sequence calculations, groove widths were localized to nucleotides 20--25 for the RER and 15--19 for the *RHO* promoter. Calculations and statistics were performed in R v3.4.0, and data were plotted using ggplot2, [ggridges v0.4.0](https://github.com/clauswilke/ggridges), and [cowplot](https://github.com/wilkelab/cowplot) v0.9.2.9900 \[[@r31],[@r32]\].

CRX docking
-----------

CRX was bound to the RER and *RHO* sequences through High Ambiguity-Driven protein-protein DOCKing (HADDOCK) to determine the interaction mechanism \[[@r33],[@r34]\]. The previously modeled CRX DNA binding domain structure consisting of residues 39--98 was used in the docking simulations with the energy minimized average structures from the promoter and RER simulations. Active residues for CRX include amino acids 40--46, 63, 69, 82, 84--85, and 88--93 \[[@r26]\]. Active residues for the DNA molecules were bases 20--25 for the RER and 15--19 for the *RHO* promoter. CRX was then docked to the sequences using the Prediction interface on the HADDOCK server. We then used YASARA to determine the interactions occurring between the residues and the consensus sequence.

Results
=======

DNA methylation is inversely correlated with gene expression of photoreceptor-specific genes in human ocular tissues
--------------------------------------------------------------------------------------------------------------------

Previous reports in the literature have demonstrated an inverse correlation between DNA methylation and gene expression of photoreceptor-specific genes \[[@r11],[@r12],[@r35]\]. These studies have been limited, however, to murine model organisms or immortalized human cell lines and have yet to be characterized in primary human tissues. To determine whether this trend is also observed in human ocular tissues, corneas and retinas were collected from three sex-matched postmortem eyes procured from human donors 75 years or older (Appendix 1). DNAs extracted from these tissues were used for quantitative bisulfite pyrosequencing analysis of DNA methylation on 5′ regulatory regions upstream of the phototransduction genes *RHO* ([Figure 1A](#f1){ref-type="fig"}) and *PDE6B* (Gene ID: 5158 OMIM: [180072](https://www.omim.org/entry/180072); [Figure 1B](#f1){ref-type="fig"}), the embryonic eye field transcription factor *PAX6* (Gene ID: 5080; OMIM: [607108](https://www.omim.org/entry/607108)), and the multicopy long interspersed nuclear element (LINE1) retrotransposon repeats. The rod-specific genes *RHO* and *PDE6B* have been previously shown to have cell-specific patterns of gene expression in murine and human rod photoreceptors \[[@r11],[@r12],[@r36]\]. Previous human retina RNA-sequencing transcriptome data demonstrate that these rod-specific genes are highly transcribed in the adult human retina ([Figure 1](#f1){ref-type="fig"}) \[[@r23]\]. Bisulfite pyrosequencing analysis of conserved 5′ regulatory regions upstream of *RHO* and *PDE6B* demonstrate lower levels of DNA methylation in retinal tissue relative to the cornea, a tissue in which neither gene is expressed ([Figure 2A,B](#f2){ref-type="fig"}). Levels of global DNA methylation between retina and corneal tissues were determined to be similar based on measurement of the constitutively methylated and silent LINE1 retrotransposon repeats, as well as the unmethylated embryonic eye field transcription factor *PAX6* ([Figure 2C,D](#f2){ref-type="fig"}). Collectively, these data demonstrate an inverse correlation between DNA methylation and transcription of *RHO* and *PDE6B* in human ocular tissues. These findings are consistent with previous observations of epigenetic regulation of phototransduction genes in the mouse retina, as well as immortalized cell lines derived from human retinal tissue.

![UCSC Genome Browser views of the *RHO* (**A**) and the 5′ region of *PDE6B* (**B**) photoreceptor-specific genes in the human hg19 genome assembly. Genes are oriented with the transcriptional start site on the left. From top to bottom, data tracks display 1) human hg19 genome coordinates, 2) human adult retina RNA sequencing data displayed as determined by Farkas et al. \[[@r23]\], 3) predicted CRX binding regions (CBRs), 4) previously validated CRX binding motifs in the *RHO* locus (black) or predicted CRX binding motifs in the *PDE6B* locus, 5) annotated genes and isoforms, and 6) evolutionarily conserved sequences averaged between 100 vertebrate species. Regions analyzed using bisulfite (BS) pyrosequencing are indicated with light blue highlighting.](mv-v24-218-f1){#f1}

![Quantitative bisulfite pyrosequencing analysis of DNA methylation at CpG sites relative to the transcriptional start site of (**A**) *RHO,* (**B**) *PDE6B*, (**C**) LINE1 retrotransposon repeats, and (**D**) *PAX6.* Data are presented as percentage methylation at the indicated genomic positions relative to the gene's canonical transcriptional start site (TSS) with the exception of LINE1 repeats in which the promoter CpG sites are arbitrarily labeled as positions 1--3. Error bars represent the standard error of the mean between three biological replicates of each sample (note that the error bars are present but too small to see in panels **A**, **C**, and **D**). Statistical significance between the retina and the cornea at each CpG site was determined with a *t* test with a p value of less than 0.01. All CpG sites analyzed at all four loci were found to have a p value of less than 0.01 between the sample groups.](mv-v24-218-f2){#f2}

Differentially methylated regions upstream of photoreceptor-specific genes correspond to CRX binding sites
----------------------------------------------------------------------------------------------------------

The epigenetic analysis of the human eye in this study demonstrates tissue-specific patterns of DNA methylation in 5′ regulatory sequences of photoreceptor-specific genes that are inversely correlated with mRNA expression. These and previous observations in other mammalian retinal model systems suggest a functional role for DNA methylation in repressing transcription at these loci. However, a mechanism for this repression remains uncharacterized. A commonality between *RHO*, *PDE6B*, and many other photoreceptor-specific genes is that they are transcriptionally regulated by the homeodomain transcription factor CRX \[[@r19],[@r36],[@r37]\]. This observation led us to question whether DNA methylation plays a role in regulating temporal and cell-specific binding of CRX to cis-regulatory regions within photoreceptor genomes. To test this hypothesis, we used a computational approach to align previously determined genome-wide CBRs in the rod-rich wild-type mouse retina to the human hg19 2009 genome assembly ([Figure 1](#f1){ref-type="fig"}; Predicted CBRs). To further assess the functionality of these presumptive regulatory regions, predicted CBRs were searched for sequences containing CRX binding motifs in the human *PDE6B* upstream promoter region ([Figure 1](#f1){ref-type="fig"}) or experimentally validated CRX binding sites in the human *RHO* locus ([Figure 3](#f3){ref-type="fig"}). These analyses demonstrated that differentially methylated regions (DMRs) identified in this study are adjacent to experimentally validated CRX binding sites in the well-characterized *RHO* 5′ promoter and RER, as well as predicted CRX binding sites in the *PDE6B* 5′ promoter. Given these results, we predict that differential methylation of these CpG sites may play a prominent role in modulating CRX binding to cis-regulatory elements upstream of *RHO*, *PDE6B,* and other CRX-regulated genes.

![Single base resolution view of the human *RHO* promoter (top) and RER (bottom) in the UCSC Genome Browser's hg38 human genome assembly aligned with five other vertebrate species. The experimentally validated CRX binding sites RET-1 and BAT-1 \[[@r17]\] in the promoter region and RHBS-1 and Ret-3 \[[@r53]\] in the enhancer region are indicated with light blue highlighting. The sequence used in the CRX/promoter binding simulations is indicated as a black custom track.](mv-v24-218-f3){#f3}

The CRX DNA binding domain interacts with DNA grooves but not known methylation sites
-------------------------------------------------------------------------------------

DNA methylation is known to alter the three-dimensional structure of double-stranded DNA and interactions with DNA binding proteins, such as transcription factors \[[@r38],[@r39]\]. Computational modeling data suggest that the presence of a bulky methyl group in 5mC results in widening of the major groove and a concomitant narrowing of the minor groove \[[@r39]\]. Further, it has been experimentally validated that 5mC DNA bases biochemically mimic thymine bases due to a similar hydrophobic interaction with major groove edge methyl groups \[[@r40]\]. More recent evidence has demonstrated a structural basis for affinity modulation of human transcription factors to methylated DNA via interactions of hydrophobic amino acid residues with methyl groups \[[@r38]\]. Taken together, these observations suggest a mechanism for DNA methylation to narrow minor groove width and increase available hydrophobic interactions of cis-regulatory elements as a reversible mode of modulating CRX binding. However, a lack of CRX structural information, as well as the interactions of CRX with DNA, has hindered development of a specific mechanism. To test the hypothesis that methylated DNA sequences are less favorable binding partners with CRX than their unmethylated counterparts, we generated a homology model of the human CRX DNA binding domain and models of the human *RHO* promoter and RER. The CRX binding domain model showed the expected three-helix bundle characteristic of a helix-turn-helix homeobox protein ([Figure 4](#f4){ref-type="fig"}). In the promoter and RER, the modeled DNA duplexes spanned one experimentally validated CRX binding site, as well as one (promoter) or two (RER) CpG cytosine substrates for DNA methylation. We then docked the model of CRX to the DNA models using HADDOCK ([Figure 4A,B](#f4){ref-type="fig"}) \[[@r34]\]. The CRX binding site within the promoter is within the minor groove, and the C-terminal helix of CRX fits into the groove making contact with the DNA backbone. Glutamic acid 80, lysine 88, and arginine 90 are known disease-causing mutations within CRX, and in our model of CRX bound to DNA, we saw that K88 and R90 make electrostatic interactions with DNA \[[@r41]-[@r43]\]. E80 makes contact with R69 and Q84, which contact the minor groove of DNA, suggesting a structural role for this amino acid ([Figure 4C,D](#f4){ref-type="fig"}). Thus, we felt confident that this CRX model could provide insight into how CRX interacts with DNA and is regulated by methylation. We next repeated the docking to the CRX binding sequence in the RER. The best interaction score produced by HADDOCK placed CRX in the major groove side of the CRX binding sequence. In addition to the previous backbone interactions noted for the promoter, CRX makes interactions with the DNA bases via N89 and K93 ([Figure 4C,D](#f4){ref-type="fig"}). Given that there currently is no structural information on CRX or these DNA sequences beyond the models we present here, we cannot exclude either binding mode. What is clear is that CRX likely interacts with a single DNA groove and does not make direct contact with methylation sites at this locus. These data suggest a mechanism of inhibition based on direct interaction with the CpG methyl sites is unlikely.

![Model of human CRX bound to the human *RHO* promoter (**A**) and RER (**B**). The CRX binding domain is shown in red, the methylation sites in magenta, and the CRX binding sequence in green. **C** and **D**: Validation of the CRX model using disease-linked amino acids. Labeled amino acids are either in close proximity to DNA or interact with DNA binding amino acids.](mv-v24-218-f4){#f4}

CpG methylation enhances DNA flexibility
----------------------------------------

The data showing that CpG methylation negatively regulates CRX binding raises the question of the molecular mechanism for binding inhibition. In addition to steric effects, CpG methylation have been proposed to change DNA dynamics and change the local structure of DNA; however, which of these scenarios applies to CRX was not clear \[[@r38],[@r39],[@r44]\]. To address this question of the inhibition mechanism, we created a second set of DNA models that were methylated at the known sites, and then, we equilibrated the models using molecular dynamics. We then analyzed the global and local effects of CpG methylation on the dynamics and structure of the DNA sequences and the CRX binding sites. Groove width statistics for these simulations are summarized in [Table 2](#t2){ref-type="table"}. Although the mean and median values for the groove widths are similar, global analysis of the major and minor grooves shows that the two structures are more dynamic ([Table 2](#t2){ref-type="table"} and [Figure 5](#f5){ref-type="fig"}). The increase in flexibility is indicated by the increased variance and standard deviations of the data measurements and visually by the wider distribution of values in the density plots ([Table 2](#t2){ref-type="table"} and [Figure 5](#f5){ref-type="fig"}). Analysis of the ensemble volume ratio shows that the structures of the methylated promoter have a larger volume, characteristic of higher dynamics. The effect of methylation is more apparent in the groove width measurement for the CRX binding sequence bases, which show wider major grooves and narrower minor grooves ([Figure 5](#f5){ref-type="fig"}). These data show that the binding site is part of the dynamic region of DNA suggested by the global values calculated from the simulation. Moreover, the observations indicate that methylation does not alter the structure of DNA or the CRX binding site within the *RHO* promoter but changes the dynamics of the structure.

###### DNA groove width statistics.

  **Sequence**   **Modification**   **Groove**   **Mean width** **(Å)**   **Std. Dev** **(Å)**   **Median** **(Å)**   **Variance** **(Å)**   **Ensemble Volume** **Ratio^a^**
  -------------- ------------------ ------------ ------------------------ ---------------------- -------------------- ---------------------- ----------------------------------
  RER            None               Major        20.72                    3.22                   20.65                10.37                  5.5
  Minor          14.88              2.01         14.80                    4.05                                                               
  Methyl         Major              21.55        4.19                     21.01                  17.56                6.8                    
  Minor          14.65              1.79         14.71                    3.20                                                               
  Promoter       None               Major        20.04                    1.00                   20.18                1.00                   4.6
  Minor          14.23              1.61         14.26                    2.59                                                               
  Methyl         Major              20.01        1.42                     20.28                  2.02                 4.9                    
  Minor          14.43              1.64         14.37                    2.67                                                               

**^a^**Ratio of the combined volume of the ensemble of structures to the average volume of each structure in the ensemble

![Structural and dynamic effects of methylation on the *RHO* promoter. **A**: Density plots for the major groove. **B**: The methylated major groove. **C**: The minor groove. **D**: Methylated minor groove widths for the methylated. The nucleotides within the CRX binding region are shown in green, and the methylation site is indicated in magenta. The mean groove width for each groove during the simulation is indicated as a dashed vertical line.](mv-v24-218-f5){#f5}

We then performed molecular dynamics simulations and analyses using the human RER sequence, which is methylated at sites on either side of the CRX binding motif. Methylation of the RER induced increased bending of the RER sequence in simulations relative to the unmodified sequence ([Figure 6](#f6){ref-type="fig"}). Further analysis of the groove widths in the RER sequence showed that with methylation the major groove widens while the minor groove narrows relative to the unmodified form ([Figure 6](#f6){ref-type="fig"} and [Table 2](#t2){ref-type="table"}). The standard deviation and variance for the major groove also increase, indicative of increased dynamics. The ensemble volume ratio increased by about 25% suggesting drastic changes in the dynamics of the RER upon methylation. The effect of methylation is especially apparent in the density plots showing data for the CRX binding site ([Figure 6](#f6){ref-type="fig"}). The bases in the major groove that include the CRX binding show a population of wider measurements that is not observed in the unmodified simulations. There are notable changes in the minor groove measurements upon methylation as well. Collectively, these data show that the presence of methylation alters the dynamics of DNA and the groove widths, possibly preventing efficient binding by CRX to the promoter and RER sequence.

![Structural and dynamic effects of methylation on the RER sequence. **A**: Density plots for the major groove. **B**: The methylated major groove. **C**: The minor groove. **D**: The methylated minor groove widths for the methylated. The nucleotides within the CRX binding region are shown in green, and the methylation site is indicated in magenta. The mean groove width for each groove during the simulation is indicated as a dashed vertical line.](mv-v24-218-f6){#f6}

Discussion
==========

Using cellular and in silico approaches, we addressed the regulation of CRX binding to genomic cis-regulatory elements and propose a model for epigenetic modulation of this interaction. Bisulfite pyrosequencing of human ocular tissue demonstrates that the *RHO* and *PDE6B* regulatory regions have lower levels of DNA methylation in the retina compared to corneal tissues ([Figure 2](#f2){ref-type="fig"}). Given that CRX binds and regulates both genes, we postulated that CRX binding is inhibited by methylation of these regions upstream of the gene in non-expressing cells to block transcription. Although this hypothesis will be best tested using biochemical methods, molecular modeling of the CRX DNA binding domain docked to CRX binding motifs within human *RHO* cis-regulatory elements was used in this study to demonstrate a basis for this model and to guide future biochemical experiments. To this end, the modeling data suggest that CRX interacts with the grooves of DNA and does not appear to make direct contact with methylation sites. Though CpG methyl sites do not occur within the CRX binding motifs analyzed in this study ([Figure 4](#f4){ref-type="fig"}), molecular dynamics simulations demonstrated an increase in the overall structural dynamics and flexibility of CRX motifs adjacent to methyl CpG sites relative to data simulations of unmethylated sequences ([Figure 5](#f5){ref-type="fig"}, [Figure 6](#f6){ref-type="fig"}, and [Table 2](#t2){ref-type="table"}). Collectively, these data indicate that regional methylation of the *RHO* promoter and RER cis-regulatory elements may occlude CRX binding through alterations in the structure and dynamics of adjacent CRX binding motifs. An additional possibility unexplored in this study is that DNA methylation is an indirect effector of CRX affinity to cis-regulatory elements. Changes in DNA methylation are known to induce other repressive epigenetic modifications, such as histone deacetylation and histone methylation \[[@r45],[@r46]\]. The present experiments of our group focus on validating these in silico data using in vitro binding assays between recombinant human CRX proteins and methylated oligonucleotides to biochemically test a direct role for DNA methylation in modulating CRX binding affinity.

The role of DNA methylation in CRX affinity has not been previously explored; however, the effect of methylation on DNA structure and interactions with DNA binding proteins has been extensively studied. DNA methylation is known to affect local and regional DNA and nucleosome structure. Recent work indicates that DNA methylation reduces DNA flexibility and enhances nucleosome stability \[[@r44],[@r47],[@r48]\]. However, other findings suggest that DNA methylation increases DNA flexibility or acts as a physical block to transcription factor binding \[[@r49]-[@r51]\]. In a broad sense, the present results are consistent with methylation increasing DNA flexibility with a few important clarifications. The first clarification regards positioning of the CpG methyl sites. The methylation sites investigated in this study are outside the CRX binding motif and therefore, likely do not act as a direct physical barrier to protein binding as characterized in other studies \[[@r38]\]. Alternatively, the present findings indicate that CpG methyl sites adjacent to CRX binding motifs change the dynamics of the major and minor grooves over the entire sequence region, including the CRX binding motif ([Figure 5](#f5){ref-type="fig"} and [Figure 6](#f6){ref-type="fig"}). This mode of epigenetic regulation may be used by cells to dynamically modulate binding of many different transcription factors at a particular regulatory locus and represents a potentially new paradigm for exploring the role of DNA methylation in regulating gene expression.

The second clarification regards motif-specific epigenetic modulation of CRX-DNA interactions. Previous studies have indicated that the specific mechanism of interaction between proteins and CpG methyl sites appears to be highly sequence and factor dependent. Global analysis of the effects of DNA methylation on several transcription factors shows that CpG methylation can have positive, neutral, and negative effects suggesting that the molecular mechanism may be a combination of effects on specific proteins binding to specific loci \[[@r38]\]. The present data also support a model for DNA methylation influencing motif-specific effects on local DNA--protein interactions. The molecular dynamics data indicate a methylated *RHO* promoter CpG site is less perturbed than the effect observed for methylated RER CpG sites ([Figure 5](#f5){ref-type="fig"} and [Figure 6](#f6){ref-type="fig"}). Given that the *RHO* promoter and RER have little sequence similarity outside conserved transcription factor binding motifs, it is not surprising that we observed distinct effects on structure and dynamics. In fact, recent functional evidence has demonstrated that individual CRX binding motifs within the murine *RHO* locus encode differential transcriptional responses to CRX ranging from strong inhibition of transcription to strong transcriptional activation \[[@r52]\]. The present data indicate that the methyl CpG adjacent to the CRX binding motif in the *RHO* promoter increases the width of the minor groove ([Table 2](#t2){ref-type="table"}). Inversely, CpG methyl sites adjacent to the RER CRX motif increase the width of the major groove in the present study simulations. This discrepancy may be due to several sequence-related differences between the two cis-regulatory elements controlling human *RHO* transcription. Collectively, these data support that the effect of DNA methylation on CRX binding is likely a combination of local and regional DNA sequences, the distance of the CpG methyl sites from CRX motifs, and the number of CpG methyl sites in or adjacent to CRX motifs. In this light, although these data support a negative effect of DNA methylation on CRX binding at the *RHO* promoter and the enhancer region, these findings do not preclude the possibility that DNA methylation may serve as a positive regulator of CRX binding at other loci in the genomes of retinal neurons. Future modeling studies of other CRX-regulated genes will be useful for further analyzing motif-specific epigenetic modulation of CRX affinity. The modeling data reported here and in future studies will guide precision biochemical analysis of the interaction between CRX with CpG methyl sites at diverse photoreceptor-specific cis-regulatory elements. In particular, these studies have informed our current ongoing biochemical analysis using recombinantly expressed human CRX proteins for in vitro binding assays measuring affinity to methylated and unmethylated regulatory sequences upstream of the human *RHO* gene. The in silico data reported here provide a single base resolution roadmap of cis-regulatory elements controlling the *RHO* locus to focus on for biochemical validation of our hypothesis.

We wish to acknowledge C.E.B. as co-corresponding author who can be contacted at berndsce\@jmu.edu or R.A.E. can be contacted at enkera\@jmu.edu. The authors would like to thank the students in CHEM361, especially Megan E. Harris, Taylor L. Hutchinson, Justin M. Kidd, Lindsay R. Kohler, Gregory J. Salamon, Alexander L. Schmidt, and Madison D. Thomas for their efforts to the modeling in the early stages of this project as well as Courtney Stout for her contributions to the project. This work was supported by NSF-REU (CHE1461175) awarded to the JMU Department of Chemistry and Biochemistry, Commonwealth Health Research Board grant \#216-05-15 awarded to RAE, a JMU 4-VA Collaborative Research Grant awarded to RAE, and Burroughs Wellcome Fund Grant \#1017506 awarded to RAE. Undergraduate students working on this project were also supported by endowed summer research scholarships provided by JMU alums Mr. and Mrs. Robert Crabtree and Jeffery E. Tickle to whom we thank for their generous support.

Post-mortem human eye tissue collection strategy. (left) Whole globe image of human eye. (right) Cornea was dissected and collected followed by removal of anterior portion of the eye, flattening of the posterior pole, and collection of the retina. To access the data, click or select the words "[Appendix 1](http://www.molvis.org/molvis/v24/appendices/mv-v24-218-app-1.docx)"
